Merck, Sanofi Will Combine Intervet, Merial Animal Health Units Into Joint Venture
cattlenetwork.com
Merck & Co. and Sanofi-Aventis SA said they will combine animal health businesses into a 50-50 joint venture, a marriage that will account for more than a quarter of the $19 billion global market for vaccines and other products for livestock and pets.
The joint venture, between Merck’s Intervet animal health unit and its Sanofi counterpart, Merial, is still subject to approval from antitrust regulators in the U.S. and Europe, the companies said in a statement announcing the transaction today.
